Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
about
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury.Effects of PARP-1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy Antigen Receptor for Chemokines.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Inhibition of poly(adenosine diphosphate-ribose) polymerase attenuates ventilator-induced lung injury.
P2860
Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Intratracheal poly (ADP) ribos ...... g ischemia reperfusion injury.
@en
type
label
Intratracheal poly (ADP) ribos ...... g ischemia reperfusion injury.
@en
prefLabel
Intratracheal poly (ADP) ribos ...... g ischemia reperfusion injury.
@en
P2093
P1476
Intratracheal poly (ADP) ribos ...... g ischemia reperfusion injury.
@en
P2093
Alexander S Farivar
Andrew L Salzman
Charles H Fraga
Csaba Szabo
Michael S Mulligan
Robert Thomas
Steven M Woolley
P304
P356
10.1016/J.ATHORACSUR.2003.10.120
P407
P577
2004-06-01T00:00:00Z